Wuhan General Group (china), Inc. (PN) Stock Price - WUHN

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Wuhan General Group (china), Inc. (PN) WUHN OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.01 -20.0% 0.04 0.05 0.04 0.05 0.05 15:22:44
Bid Price Ask Price Spread Spread % News
0.0352 0.06 0.0248 41.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 21,244 $ 0.045293 $ 962 34,019 0.025 - 0.485
Last Trade Time Type Quantity Stock Price Currency
15:02:35 10,000 $ 0.04 USD

Wuhan General Group (china), Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.16M 43.27M $ -10.59M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.84k $ - 0.00% - -

more financials information »

Wuhan General Group (china), Inc. (PN) News

Loading Messages....

Latest WUHN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical WUHN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.040.050.03120.0416929,0910.000.0%
1 Month0.11750.13290.0250.058650271,319-0.0775-65.96%
3 Months0.1750.1990.0250.088132133,980-0.135-77.14%
6 Months0.31950.4850.0250.216281857,397-0.2795-87.48%
1 Year0.223450.4850.0250.213289547,959-0.18345-82.1%
3 Years0.030.830.010.255002243,0740.0133.33%
5 Years0.19990.830.010.248026936,166-0.1599-79.99%

Wuhan General Group (china), Inc. (PN) Description

Wuhan General Group (China), Inc. through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company that research, develops and commercializes a range of CBD-based products under the Dr. AnnaRx brand. In addition, its new division, M2BIO aims to explore and develop additional indications for psilocybin new therapies that will help patients who suffer from mental illness. Our mission is to advance botanical-based medicine to the forefront by deploying best practice science and medicine, clinical research and emerging technologies.

Your Recent History
Wuhan Gene..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.